BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang B, Zhang W, Zhou X, Liu M, Hou X, Cheng Z, Chen D. Development of dual-targeted nano-dandelion based on an oligomeric hyaluronic acid polymer targeting tumor-associated macrophages for combination therapy of non-small cell lung cancer. Drug Deliv 2019;26:1265-79. [PMID: 31777307 DOI: 10.1080/10717544.2019.1693707] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Qin Y, Tang M. Pueraria lobata Targeted Preparation Improves the Clinical Symptoms of Cervical Spondylosis by Regulating the Balance of Gut Microbiota. Computational and Mathematical Methods in Medicine 2022;2022:1-8. [DOI: 10.1155/2022/2136807] [Reference Citation Analysis]
2 Zeng Y, Xiang Y, Sheng R, Tomás H, Rodrigues J, Gu Z, Zhang H, Gong Q, Luo K. Polysaccharide-based nanomedicines for cancer immunotherapy: A review. Bioactive Materials 2021;6:3358-82. [DOI: 10.1016/j.bioactmat.2021.03.008] [Reference Citation Analysis]
3 Shi L, Gu H. Emerging Nanoparticle Strategies for Modulating Tumor-Associated Macrophage Polarization. Biomolecules 2021;11:1912. [PMID: 34944555 DOI: 10.3390/biom11121912] [Reference Citation Analysis]
4 Siddique S, Chow JCL. Application of Nanomaterials in Biomedical Imaging and Cancer Therapy. Nanomaterials (Basel) 2020;10:E1700. [PMID: 32872399 DOI: 10.3390/nano10091700] [Cited by in Crossref: 46] [Cited by in F6Publishing: 32] [Article Influence: 23.0] [Reference Citation Analysis]
5 Fang L, Lin H, Wu Z, Wang Z, Fan X, Cheng Z, Hou X, Chen D. In vitro/vivo evaluation of novel mitochondrial targeting charge-reversal polysaccharide-based antitumor nanoparticle. Carbohydrate Polymers 2020;234:115930. [DOI: 10.1016/j.carbpol.2020.115930] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
6 Wang J, Li Q, Xue J, Chen W, Zhang R, Xing D. Shape matters: Morphologically biomimetic particles for improved drug delivery. Chemical Engineering Journal 2021;410:127849. [DOI: 10.1016/j.cej.2020.127849] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
7 Jiang X, Lin M, Huang J, Mo M, Liu H, Jiang Y, Cai X, Leung W, Xu C. Smart Responsive Nanoformulation for Targeted Delivery of Active Compounds From Traditional Chinese Medicine. Front Chem 2020;8:559159. [PMID: 33363102 DOI: 10.3389/fchem.2020.559159] [Reference Citation Analysis]
8 Zhu D, Lu Y, Gui L, Wang W, Hu X, Chen S, Wang Y, Wang Y. Self-assembling, pH-responsive nanoflowers for inhibiting PAD4 and neutrophil extracellular trap formation and improving the tumor immune microenvironment. Acta Pharm Sin B 2022;12:2592-608. [PMID: 35646534 DOI: 10.1016/j.apsb.2021.11.006] [Reference Citation Analysis]
9 Cheng Z, Lin H, Wang Z, Yang X, Zhang M, Liu X, Wang B, Wu Z, Chen D. Preparation and characterization of dissolving hyaluronic acid composite microneedles loaded micelles for delivery of curcumin. Drug Deliv and Transl Res 2020;10:1520-30. [DOI: 10.1007/s13346-020-00735-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
10 Singh S, Meena A, Luqman S. Baicalin mediated regulation of key signaling pathways in cancer. Pharmacol Res 2021;164:105387. [PMID: 33352232 DOI: 10.1016/j.phrs.2020.105387] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
11 Hu J, Tan X, Wang D, Li Y, Liang H, Peng J, Li F, Zhou Q, Geng P, Wang S, Yu Y, Liu J. A stepwise-targeting strategy for the treatment of cerebral ischemic stroke. J Nanobiotechnology 2021;19:371. [PMID: 34789285 DOI: 10.1186/s12951-021-01118-6] [Reference Citation Analysis]
12 Zeng Y, Xiang Y, Sheng R, Tomás H, Rodrigues J, Gu Z, Zhang H, Gong Q, Luo K. Polysaccharide-based nanomedicines for cancer immunotherapy: A review. Bioact Mater 2021;6:3358-82. [PMID: 33817416 DOI: 10.1016/j.bioactmat.2021.03.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
13 Berdiaki A, Neagu M, Giatagana EM, Kuskov A, Tsatsakis AM, Tzanakakis GN, Nikitovic D. Glycosaminoglycans: Carriers and Targets for Tailored Anti-Cancer Therapy. Biomolecules 2021;11:395. [PMID: 33800172 DOI: 10.3390/biom11030395] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Zhou X, Jin T, Wang L, Zhao E, Xiao X. Clinical practice of epidermal growth factor receptor-tyrosine kinase inhibitor targeted drugs combined with gadolinium oxide nanoparticles in the treatment of non-small cell lung cancer. Bioengineered 2022;13:128-39. [PMID: 34818973 DOI: 10.1080/21655979.2021.2009969] [Reference Citation Analysis]
15 Ghanbari-Movahed M, Mondal A, Farzaei MH, Bishayee A. Quercetin- and rutin-based nano-formulations for cancer treatment: A systematic review of improved efficacy and molecular mechanisms. Phytomedicine 2021;97:153909. [PMID: 35092896 DOI: 10.1016/j.phymed.2021.153909] [Reference Citation Analysis]
16 Quagliariello V, Gennari A, Jain SA, Rosso F, Iaffaioli RV, Barbarisi A, Barbarisi M, Tirelli N. Double-responsive hyaluronic acid-based prodrugs for efficient tumour targeting. Mater Sci Eng C Mater Biol Appl 2021;131:112475. [PMID: 34857264 DOI: 10.1016/j.msec.2021.112475] [Reference Citation Analysis]
17 Xiang L, Gao Y, Chen S, Sun J, Wu J, Meng X. Therapeutic potential of Scutellaria baicalensis Georgi in lung cancer therapy. Phytomedicine 2021;:153727. [PMID: 34535372 DOI: 10.1016/j.phymed.2021.153727] [Reference Citation Analysis]
18 Liu X, Wu Z, Guo C, Guo H, Su Y, Chen Q, Sun C, Liu Q, Chen D, Mu H. Hypoxia responsive nano-drug delivery system based on angelica polysaccharide for liver cancer therapy. Drug Deliv 2022;29:138-48. [PMID: 34967268 DOI: 10.1080/10717544.2021.2021324] [Reference Citation Analysis]
19 Xu T, Yu S, Zhang J, Wu S. Dysregulated tumor-associated macrophages in carcinogenesis, progression and targeted therapy of gynecological and breast cancers. J Hematol Oncol 2021;14:181. [PMID: 34717710 DOI: 10.1186/s13045-021-01198-9] [Reference Citation Analysis]
20 Masuelli L, Benvenuto M, Focaccetti C, Ciuffa S, Fazi S, Bei A, Miele MT, Piredda L, Manzari V, Modesti A, Bei R. Targeting the tumor immune microenvironment with "nutraceuticals": From bench to clinical trials. Pharmacol Ther 2021;219:107700. [PMID: 33045254 DOI: 10.1016/j.pharmthera.2020.107700] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]